💫𝐇𝐎𝐓 𝐍𝐄𝐖𝐒💫
The global usage of Ketorolac Tromethamine, a nonsteroidal anti-inflammatory drug (NSAID), is seeing significant growth due to its effectiveness in managing acute pain and its applications in ophthalmic surgery. In 2023, the market for Ketorolac Tromethamine was valued at approximately $251.1 million and is projected to grow to around $350.5 million by 2030, with a compound annual growth rate (CAGR) of 𝟒.𝟗% during this period.
North America, particularly the U.S., dominates the market, with a projected revenue of $290 million in 2024, followed by Europe and the Asia-Pacific region. The demand in Asia-Pacific is expected to grow at a faster rate (CAGR of 𝟏𝟑.𝟓%) compared to other regions, driven largely by increasing healthcare access and demand for pain management solutions. Meanwhile, countries like China, India, and Japan are seeing rapid market expansion due to rising healthcare investments and increasing population demand for effective analgesics.
🎉 Let 𝐂𝐏𝐂𝟏𝐇𝐍 helps you to dominate this promising market with 𝐊𝐞𝐭𝐨𝐫𝐨𝐥𝐚𝐜-𝐁𝐅𝐒:
𝐓𝐡𝐞 𝐁𝐅𝐒 (𝐁𝐥𝐨𝐰, 𝐅𝐢𝐥𝐥, 𝐒𝐞𝐚𝐥) 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 is a manufacturing process for liquid medications contained in plastic bottles/vials as a replacement for glass vials, following a fully automated and continuous process. BFS technology is recognized by the FDA (U.S. Food and Drug Administration) as a high-grade aseptic process, used to produce injections /eye drops/aerosols.
📩 𝗖𝗢𝗡𝗧𝗔𝗖𝗧 𝗨𝗦 𝗡𝗢𝗪
𝗠𝐫𝐬. 𝐓𝐡𝐚𝐧𝐡 𝐗𝐮𝐚𝐧 – 𝗘𝘅𝗽𝗼𝗿𝘁 𝐃𝐢𝐫𝐞𝐜𝐭𝐨𝐫
𝑴𝒐𝒃𝒊𝒍𝒆/𝑾𝒉𝒂𝒕𝒔𝒂𝒑𝒑/𝑻𝒆𝒍𝒆𝒈𝒓𝒂𝒎/𝑽𝒊𝒃𝒆𝒓: +84 984 404 650
𝑬𝒎𝒂𝒊𝒍: export@cpc1hn.vn
𝑾𝒆𝒃𝒔𝒊𝒕𝒆: https://cpc1hn.com/
𝑯𝒂𝒏𝒐𝒊 𝑪𝑷𝑪1 𝑷𝒉𝒂𝒓𝒎𝒂𝒄𝒆𝒖𝒕𝒊𝒄𝒂𝒍 – 𝑫𝒊𝒇𝒇𝒆𝒓𝒆𝒏𝒕 𝒘𝒊𝒕𝒉 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚

#PainManagement #PharmaInnovation #GlobalHealth #Surgery #BFSProcess #PharmaceuticalManufacturing #HealthcareSolutions #AsepticTechnology #MedicalInnovation #FDAApproved #DrugMarketGrowth